Menu
GeneBe

9-34459027-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012144.4(DNAI1):c.22G>T(p.Ala8Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0616 in 1,613,884 control chromosomes in the GnomAD database, including 3,592 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A8P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.050 ( 271 hom., cov: 32)
Exomes 𝑓: 0.063 ( 3321 hom. )

Consequence

DNAI1
NM_012144.4 missense

Scores

14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.40
Variant links:
Genes affected
DNAI1 (HGNC:2954): (dynein axonemal intermediate chain 1) This gene encodes a member of the dynein intermediate chain family. The encoded protein is part of the dynein complex in respiratory cilia. The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia and Kartagener syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016712248).
BP6
Variant 9-34459027-G-T is Benign according to our data. Variant chr9-34459027-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 178761.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-34459027-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0634 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DNAI1NM_012144.4 linkuse as main transcriptc.22G>T p.Ala8Ser missense_variant 1/20 ENST00000242317.9
DNAI1NM_001281428.2 linkuse as main transcriptc.22G>T p.Ala8Ser missense_variant 1/20

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DNAI1ENST00000242317.9 linkuse as main transcriptc.22G>T p.Ala8Ser missense_variant 1/201 NM_012144.4 Q9UI46-1
DNAI1ENST00000614641.4 linkuse as main transcriptc.22G>T p.Ala8Ser missense_variant 1/205 P1
DNAI1ENST00000437363.5 linkuse as main transcriptc.22G>T p.Ala8Ser missense_variant 1/95
DNAI1ENST00000470982.5 linkuse as main transcriptn.47+1567G>T intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0496
AC:
7547
AN:
152090
Hom.:
271
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0133
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.0460
Gnomad ASJ
AF:
0.0473
Gnomad EAS
AF:
0.00789
Gnomad SAS
AF:
0.0448
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0651
Gnomad OTH
AF:
0.0392
GnomAD3 exomes
AF:
0.0550
AC:
13820
AN:
251398
Hom.:
471
AF XY:
0.0558
AC XY:
7584
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.0439
Gnomad ASJ exome
AF:
0.0416
Gnomad EAS exome
AF:
0.00674
Gnomad SAS exome
AF:
0.0520
Gnomad FIN exome
AF:
0.115
Gnomad NFE exome
AF:
0.0625
Gnomad OTH exome
AF:
0.0611
GnomAD4 exome
AF:
0.0629
AC:
91923
AN:
1461676
Hom.:
3321
Cov.:
31
AF XY:
0.0627
AC XY:
45619
AN XY:
727142
show subpopulations
Gnomad4 AFR exome
AF:
0.00995
Gnomad4 AMR exome
AF:
0.0443
Gnomad4 ASJ exome
AF:
0.0419
Gnomad4 EAS exome
AF:
0.00491
Gnomad4 SAS exome
AF:
0.0532
Gnomad4 FIN exome
AF:
0.112
Gnomad4 NFE exome
AF:
0.0667
Gnomad4 OTH exome
AF:
0.0565
GnomAD4 genome
AF:
0.0496
AC:
7546
AN:
152208
Hom.:
271
Cov.:
32
AF XY:
0.0505
AC XY:
3758
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.0133
Gnomad4 AMR
AF:
0.0461
Gnomad4 ASJ
AF:
0.0473
Gnomad4 EAS
AF:
0.00772
Gnomad4 SAS
AF:
0.0448
Gnomad4 FIN
AF:
0.118
Gnomad4 NFE
AF:
0.0650
Gnomad4 OTH
AF:
0.0393
Alfa
AF:
0.0512
Hom.:
199
Bravo
AF:
0.0413
TwinsUK
AF:
0.0693
AC:
257
ALSPAC
AF:
0.0701
AC:
270
ESP6500AA
AF:
0.0182
AC:
80
ESP6500EA
AF:
0.0630
AC:
542
ExAC
AF:
0.0540
AC:
6553
Asia WGS
AF:
0.0220
AC:
78
AN:
3478
EpiCase
AF:
0.0614
EpiControl
AF:
0.0563

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:4
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 01, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Ala8Ser in exon 1 of DNAI1: This variant is not expected to have clinical signif icance because it has been identified in 6.3% (542/8600) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs11547035). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.46
Cadd
Benign
9.7
Dann
Benign
0.79
DEOGEN2
Benign
0.0076
T;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.090
N
LIST_S2
Benign
0.32
T;T;T
MetaRNN
Benign
0.0017
T;T;T
MetaSVM
Benign
-0.99
T
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.34
T
Sift4G
Benign
0.70
T;T;T
Polyphen
0.0020
.;.;B
Vest4
0.080
MPC
0.10
ClinPred
0.012
T
GERP RS
2.6
Varity_R
0.043
gMVP
0.093

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11547035; hg19: chr9-34459025; API